Data analysis study of pain in patients with neuromyelitis optica using patient survey data in north America
Not Applicable
- Conditions
- euromyelitis Optica
- Registration Number
- JPRN-UMIN000033858
- Lead Sponsor
- CHUGAI PHARMACEUTICAL CO., LTD.
- Brief Summary
Pain severity was the strongest negative predictor of QoL. In the total and AQP4-IgG-seropositive groups, pain was the most common symptom that patients wanted their physician to be concerned about; in the AQP4-IgG-seronegative group, this was fatigue. For all patients, frequent hospital visits and relapses were associated with more severe pain, but not frequency of NMOSD specialist visits. Patients without recent relapse still commonly reported moderate or severe pain (>25%).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 193
Inclusion Criteria
Not provided
Exclusion Criteria
Lives in neither the United States nor Canada.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effects of pain on quality of life in patients with neuromyelitis optica
- Secondary Outcome Measures
Name Time Method